Emerging nonanticoagulant role of low molecular weight heparins on extravillous trophoblast functions and on heparin binding-epidermal growth factor and cystein-rich angiogenic inducer 61 expression

Fertility and Sterility

Volumn 98, Issue 4, 2012, Pages

  D'Ippolito, Silvia ^a   Di Nicuolo, Fiorella ^a   Marana, Riccardo ^a   Castellani, Roberta ^a   Stinson, John ^b   Tersigni, Chiara ^a   Scambia, Giovanni ^a   Di Simone, Nicoletta ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b LEO PHARMA A S   (Denmark)

Author keywords

AP 1; Cyr61; enoxaparin; Extravillous trophoblast invasiveness; HB EGF; low molecular weight heparins; MMP 2; tinzaparin

Indexed keywords

CYSTEIN RICH ANGIOGENIC INDUCER 61; ENOXAPARIN; GELATINASE A; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MEMBRANE PROTEIN; TINZAPARIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; EXTRAVILLOUS TROPHOBLAST; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SPONTANEOUS ABORTION; TRANSCRIPTION REGULATION; TROPHOBLAST;

EID: 84867023104     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.06.042     Document Type: Article

References (66)

1. G. Girardi Heparin treatment in pregnancy loss: potential therapeutic benefits beyond anticoagulation J Reprod Immunol 66 2005 45 51
2. S.M. Nelson, and I.A. Greer The potential role of heparin in assisted conception Hum Reprod Update 14 2008 623 645
3. R.L. Bick, E.P. Frenkel, J. Walenga, J. Fareed, and D.A. Hoppensteadt Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use Hematol Oncol Clin North Am 19 2005 1 51 v
4. B. Brenner, R. Hoffman, Z. Blumenfeld, Z. Weiner, and J.S. Younis Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin Thromb Haemost 83 2000 693 697
5. H. Carp, M. Dolitzky, and A. Inbal Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia J Thromb Haemost 1 2003 433 438
6. I.A. Greer Antithrombotic treatment for recurrent pregnancy loss? J Thromb Haemost 9 2011 302 305
7. H. Yamamoto, S. Fuyama, S. Arai, and F. Sendo Inhibition of mouse natural killer cytotoxicity by heparin Cell Immunol 96 1985 409 417
8. S. Johann, C. Zoller, S. Haas, G. Blumel, M. Lipp, and R. Foster Sulfated polysaccharide anticoagulants suppress natural killer cell activity in vitro Thromb Haemost 74 1995 998 1002
9. K.W. Christoperson II, J.J. Campbell, J.B. Travers, and R.A. Hromas Low-molecular weight heparins inhibit CCL21-induced T cell adhesion and migration J Pharmacol Exp Ther 302 2002 290 295
10. I. Manduteanu, M. Voinea, M. Capraru, E. Dragomir, and M. Simionescu A novel attribute of enoxaparin: inhibition of monocyte adhesion to endothelial cell adhesion molecules Pharmacology 65 2002 32 37
11. J.G. Wan, J.S. Mu, H.S. Zhu, and J.G. Geng N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo Inflamm Res 51 2002 435 443
12. S.J. Fritchley, J.A. Kirby, and S. Ali The antagonism of interferon-gamma (IFN-gamma) by heparin: examination of the blockade of class II MHC antigen and heat shock protein-70 expression Clin Exp Immunol 120 2000 247 252
13. G. Girardi, P. Redecha, and J.E. Salmon Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nat Med 10 2004 1222 1226
14. J. Folkman, and Y. Shing Control of angiogenesis by heparin and other sulfated polysaccharides Adv Exp Med 313 1992 355 364
15. Y. Li, H.Y. Wang, and C.H. Cho Association of heparin with basic fibroblast growth factor, epidermal gorwth factor and constitutive nitric oxyde synthase on healing of gastric ulcer in rats J Pharmacol Exp Ther 290 1999 789 796
16. F.A. Hills, V.M. Abrahams, B. Gonzales-Timon, J. Francis, B. Cloke, and L. Hinkson Heparin prevents programmed cell death in human trophoblast Mol Hum Reprod 12 2006 237 243
17. N. Di Simone, F. Di Nicuolo, R. Castellani, M. Veglia, C. Tersigni, and M. Silano Low-molecular-weight heparins induce decidual heparin-binding epidermal growth factor-like growth factor expression and promote survival of decidual cells undergoing apoptosis Fertil Steril 97 2012 169 177.e1
18. N. Di Simone, R. Marana, R. Castellani, F. Di Nicuolo, M.C. D'Alessio, and E. Raschi Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation Arthritis Rheum 62 2010 1504 1512
19. N. Di Simone, F. Di Nicuolo, M. Sanguinetti, S. Ferrazzani, M.C. D'Alessio, and R. Castellani Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors Placenta 28 2007 298 304
20. J.Z. Chen, P.M. Sheehan, S.P. Brennecke, and R.J. Keogh Vessel remodelling, pregnancy hormones and extravillous trophoblast function Mol Cell Endocrinol 349 2012 138 144
21. M. Cohen, A. Meisser, and P. Bischof Metalloproteinases and human placental invasiveness Placenta 27 2006 783 793
22. C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum Reprod Update 13 2007 121 141
23. G. Raab, and M. Klagsbrun Heparin binding EGF growth factor Biochim Biophys Acta 1333 1997 F179 F199
24. G. Raab, K. Kover, B.C. Paria, S.K. Dey, R.M. Ezzell, and M. Klagsbrun Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor Development 122 1996 637 645
25. S. Blotnick, G.E. Peoples, M.R. Freeman, T.J. Eberlein, and M. Klagsbrun T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4- and CD8- T cells Proc Natl Acad Sci U S A 91 1994 2890 2894
26. M.L. Kireeva, F.E. Mo, G.P. Yang, and L.F. Lau Cyr61, a product of a growth inducible immediate early gene, promotes cell proliferation, migration and adhesion Mol Cell 16 1996 1326 1334
27. A.M. Babic, M.L. Kireeva, T.V. Kolesnikova, and L.F. Lau CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth Proc Natl Acad Sci 95 1998 6355 6360
28. P. Jessmon, R.E. Leach, and D. Randal Armant Diverse functions of HBEGF during pregnancy Mol Reprod Develop 76 2009 1116 1127
29. Y. Chen, W. Xiao-Xia, J. Tan, M. Liu, Y. Liu, and J. Zhang Effect of low molecular weight heparin and heparin-binding epidermal growth factor on human trophoblast in first trimester Fertil Steril 97 2012 764 770
30. N. Wolf, W. Yang, C.E. Dunk, I. Gashaw, S.J. Lye, and T. Ring Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1α and transforming-growth factor-β3 in the human trophoblast Endocrinology 151 2010 2835 2845
31. J.M. Park, R.M. Adam, C.A. Peters, P.D. Guthrie, Z. Sun, and M. Klagsbrun AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells Am J Physiol 277 1999 294 301
32. M. Sakai, T. Tsukada, and R.C. Harris Oxidant stress activated AP-1 and heparin-binding epidermal growth factor-like growth factor transcription in renal epithelial cells Exp Nephrol 9 2001 28 39
33. J.J. You, C.M. Yang, M.S. Chen, and C.H. Yang Regulation of Cyr61/CCN1 expression by hypoxia through cooperation of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells Exp Eye Res 91 2010 825 836
34. T.W. Tan, W.H. Yang, Y.T. Lin, S.F. Hsu, T.M. Li, and S.T. Kao Cyr61 increases migration and MMP-13 expression via αvβ3 integrin, FAK, ERK and AP-1 dependent pathway in human chondrosarcoma cells Carcinogenesis 30 2009 258 268
35. N. Di Simone, N. Maggiano, D. Caliandro, P. Riccardi, A. Evangelista, and B. Carducci Homocysteine induces trophoblast cell death with apoptotic features Biol Reprod 69 2003 1129 1134
36. T.D. Burrows, A. King, and Y.W. Lokr Trophoblast migration during human placental implantation Hum Reprod Update 2 1996 307 321
37. E. Staun-Ram, S. Goldman, and E. Shalev Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion Reprod Biol Endocrinol 7 2009 135
38. K. Isaka, S. Usuda, H. Ito, Y. Sagawa, H. Nakamura, and H. Nishi Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts Placenta 24 2003 53 64
39. R. Iwamoto, and E. Mekada Heparin-binding EGF-like growth factor: a juxtacrine growth factor Cytokine Growth Factor Rev 11 2000 335 344
40. K. Chobotova, N. Karpovich, J. Carver, S. Manek, W.J. Gullick, and D.H. Barlow Heparin-binding epidermal growth factor and its receptors mediate decidualization and potentiate survival of human endometrial stromal cells J Clin Endocrinol Metab 90 2005 913 919
41. R.E. Leach, B. Kilburn, J. Wang, Z. Liu, R. Romero, and D.R. Armant Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype Dev Biol 266 2004 223 237
42. B.C. Paria, W. Ma, J. Tan, S. Raja, S.K. Das, and S.K. Dey Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors Proc Natl Acad Sci U S A 98 2001 1047 1052
43. R.E. Leach, R. Romero, Y.M. Kim, T. Chaiworapongsa, B. Kilburn, and S.K. Das Pre-eclampsia and expression of heparin-binding EGF-like growth factor Lancet 360 2002 1215 1219
44. I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero The "great obstetrical syndromes" are associated with disorders of deep placentation Am J Obstet Gynecol 204 2011 193 201
45. E. Di Federico, O. Genbacev, and S.J. Fisher Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall Am J Pathol 155 1999 293 301
46. A.D. Allaire, K.A. Ballenger, S.R. Wells, M.J. McMahon, and B.A. Lessey Placental apoptosis in preeclampsia Obstet Gynecol 96 2000 271 276
47. L.F. Lau CCN/Cyr61: the very model of a modern matricellular protein Cell Mol Life Sci 68 2011 3149 3163
48. M.L. Kireeva, S.C.T. Lam, and L.F. Lau Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αvβ2 J Biol Chem 276 1998 351 357
49. G.P. Yang, and L.F. Lau Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface Cell Growth Differ 2 1991 351 357
50. F.E. Mo, A.G. Muntean, C.C. Chen, D.B. Stolz, S.C. Watkins, and L.F. Lau CYR61 (CCN1) is essential for placental development and vascular integrity Mol Cell Biol 22 2002 8709 8720
51. Y. Zhang, Z. Diao, L. Su, H. Sun, R. Li, and H. Cui MicroRNA-155 contributes to preeclampsia by down-regulating CYR61 Am J Obstet Gynecol 202 2010 466 467
52. A. Gellhaus, M. Schmidt, C. Dunk, S.J. Lye, R. Kimmig, and E. Winterhager Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia Mol Hum Reprod 12 2006 389 399
53. A. Gellhaus, M. Schmidt, C. Dunk, S.J. Lye, and E. Winterhager The circulating proangiogenic factos CYR61 (CCN1) and NOV (CCN3) are significantly decreased in placentae and sera of preeclamptic patients Reprod Sci 14 2007 46 52
54. T. Quan, Z. Qin, Y. Xu, T. He, S. Kang, and J.J. Voorhees Ultraviolet irradiation induces CYR61/CCN1, a mediator of collagen homeostasis, through activation of transcription factor AP-1 in human skin fibroblasts J Invest Dermatol 130 2010 1690 1706
55. P. Bose, S. Black, M. Kadyrov, U. Weissenborn, J. Neulen, and L. Regan Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure Am J Obstet Gynecol 192 2005 23 30
56. G.S. Wolff, P.J. Chiang, S.M. Smith, R. Romero, and D.R. Armant Epidermal growth factor-like growth factors prevent apoptosis of alcohol-exposed human placental cytotrophoblast cells Biol Reprod 77 2007 53 60
57. K Katsube, K Sakamoto, Y Tamamura, and A Yamaguchi Role of CCN, a vertebrate specific gene family, in development Dev Growth Differ 51 2009 55 67
58. E. Recine Differentiation of the low molecular weight heparins Pharmacotherapy 21 2001 71S 72S
59. H. Takahashi, S. Ebihara, T. Okazaki, M. Asada, H. Sasaki, and M. Yamaya A comparison of the effects of unfractionated heparin, dalteparin and dapanaroid on vascular endothelial growth factor-induced tumour angiogenesis and heparanase activity Br J Pharmacol 146 2005 333 343
60. W.H. Kutteh Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone Am J Obstet Gynecol 174 1996 1584 1589
61. R. Rai, H. Cohen, M. Dave, and L. Regan Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) Br Med J 314 1997 253 257
62. A.M. Badawy, M. Khiary, L.S. Sherif, M. Hassan, A. Ragab, and I. Abdelall Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology J Obstet Gynaecol 28 2008 280 284
63. B. Urman, B. Ata, K. Yakin, C. Alatas, S. Aksoy, and R. Mercan Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial Hum Reprod 24 2009 1640 1647
64. P. Clark, I.D. Walker, P. Langhorne, L. Crichton, A. Thomson, and M. Greaves SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage Blood 115 2010 4162 4167
65. S.P. Kaandorp, M. Goddijn, J.A. van der Post, B.A. Hutten, H.R. Verhoeve, and K. Hamulyák Aspirin plus heparin or aspirin alone in women with recurrent miscarriage N Engl J Med 362 2010 1586 1596
66. I.A. Greer Antithrombotic therapy for recurrent miscarriage? N Engl J Med 362 2010 1630 1631